Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-020520
Filing Date
2019-07-29
Accepted
2019-07-29 16:05:56
Documents
1
Period of Report
2019-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10548
  Complete submission text file 0000899243-19-020520.txt   11942
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Issuer) CIK: 0001731831 (see all company filings)

EIN.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94101
Business Address
Sinha Uma (Reporting) CIK: 0001742587 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38533 | Film No.: 19981222